These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hemodynamic reaction of normotensive and hypertensive rats to the administration of prostaglandins and indomethacin]. Ismailov ShI, Val'dman AV. Biull Eksp Biol Med; 1982 Aug; 94(8):45-8. PubMed ID: 6751430 [Abstract] [Full Text] [Related]
3. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model]. Ponchon P, Elghozi JL. Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874 [Abstract] [Full Text] [Related]
4. [The effect of parathormone on the reactivity of the cardiovascular system to angiotensin-2 in normotensive and spontaneously hypertensive rats]. Brin VB, Tatrov AS. Fiziol Zh SSSR Im I M Sechenova; 1990 Mar; 76(3):345-50. PubMed ID: 2164967 [Abstract] [Full Text] [Related]
5. [Comparative evaluation of systemic hemodynamics in normotensive and hypertensive rats]. Ismailov ShI, Medvedev OS. Biull Eksp Biol Med; 1982 May; 93(5):38-40. PubMed ID: 7093505 [Abstract] [Full Text] [Related]
6. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat. Cody RJ, Binkley PF, Haas GJ, Brown DM. Am J Hypertens; 1995 May; 8(5 Pt 1):500-8. PubMed ID: 7662227 [Abstract] [Full Text] [Related]
7. Alterations in responses to bradykinin, angiotensin I, and angiotensin II during the induction phase of one-kidney, one-wrapped hypertension and associated arterial disease in rabbits. Campbell WG, Donohue JA, Duket LH. Am J Pathol; 1980 Feb; 98(2):457-84. PubMed ID: 6243872 [Abstract] [Full Text] [Related]
8. [Hemodynamic changes in the acute phase of experimental hypertension]. Carbonell LF, Salazar J, García-Estañ J, Jiménez JL, Quesada T. Rev Esp Fisiol; 1983 Jun; 39(2):155-60. PubMed ID: 6622806 [Abstract] [Full Text] [Related]
9. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats. Gonzalez Vera W, Fournié-Zaluski MC, Pham I, Laboulandine I, Roques BP, Michel JB. J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350 [Abstract] [Full Text] [Related]
10. Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats. Dubinion JH, Mi Z, Jackson EK. J Pharmacol Exp Ther; 2006 Jun; 317(3):1330-6. PubMed ID: 16537795 [Abstract] [Full Text] [Related]
11. [Functional and structural reactivity of the arterial vascular system to angiotensin II in spontaneously hypertensive rats]. Matthias D, Moritz V, Engler E, Schmidt R, Becker CH. Acta Biol Med Ger; 1981 Jun; 40(2):177-87. PubMed ID: 7269988 [Abstract] [Full Text] [Related]
12. Secretory dysfunction of vascular endothelium limits the effect of angiotensin converting enzyme inhibitor quinapril on aggregation of erythrocytes in experimental hypertension. Korbut RA, Madej J, Adamek-Guzik T, Korbut R. J Physiol Pharmacol; 2003 Sep; 54(3):397-408. PubMed ID: 14566078 [Abstract] [Full Text] [Related]
13. Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reduction. Linz W, Gohlke P, Unger T, Schölkens BA. Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():31-4. PubMed ID: 7646309 [Abstract] [Full Text] [Related]
14. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition. Guidi E, Hollenberg NK. J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668 [Abstract] [Full Text] [Related]
15. [Relationship between the kininase and angiotensin-converting lung functions in rabbits with cerebroischemic and renovascular hypertension]. Karpitskiĭ VV, Gomazkov OA. Biull Eksp Biol Med; 1982 Jan; 93(1):24-6. PubMed ID: 6279206 [No Abstract] [Full Text] [Related]
16. Evidence for a role of AT(2) receptors at the CVLM in the cardiovascular changes induced by low-intensity physical activity in renovascular hypertensive rats. Rodrigues MC, Campagnole-Santos MJ, Machado RP, Silva ME, Rocha JL, Ferreira PM, Santos RA, Alzamora AC. Peptides; 2007 Jul; 28(7):1375-82. PubMed ID: 17629353 [Abstract] [Full Text] [Related]
17. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats. Soltis EE. J Pharmacol Exp Ther; 1993 Aug; 266(2):642-6. PubMed ID: 8355197 [Abstract] [Full Text] [Related]
18. Volume and vasoconstriction in experimental renovascular hypertension. Freeman RH, Davis JO, Seymour AA. Fed Proc; 1982 Jun; 41(8):2409-14. PubMed ID: 7044827 [Abstract] [Full Text] [Related]
19. [Physiologically active peptides and the regulation of arterial pressure in normal and pathological states]. Gomazkov OA. Vopr Med Khim; 1984 Jun; 30(3):79-86. PubMed ID: 6089432 [Abstract] [Full Text] [Related]
20. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs. Hayashi N, Yamamoto S, Kometani M, Nakao K. Arzneimittelforschung; 1997 May; 47(5):620-5. PubMed ID: 9205775 [Abstract] [Full Text] [Related] Page: [Next] [New Search]